Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment of Marc Semigran, M.D., as chief medical officer of Renovacor.

Biotechnology

Renovacor

Renovacor's headquarters in Philadelphia, PA, United States

Magdalene Cook

Wendy DiCicco

Kumar Dhanasekharan

Marc Semigran

Jiwen Zhang

Matt Killeen

Beth White

Richard Peluso

Jonas Grossman

Gregory F. Covino

Joan Lau

Gbola Amusa

Lee Sweeney

Edward J Benz

Arthur Feldman

Dennis McNamara

Thomas Needham

Douglas Mann

Joseph Glorioso III

Michael Bristow

Description

People (1)

Arthur Feldman

Jobs